BPA Call 75F40118A10050-75F40120F19006

Award Date 3/31/20
Potential Completion Date 3/31/21
Potential Value $7M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $5.6 million contract to Booz Allen Hamilton Inc. to provide Drug Quality and Security Services under its Multiple Award Schedule contract vehicle. The contract calls for Booz Allen Hamilton to support the FDA's DQSA program through labor-hour services such as quality control analysis, supply chain security assessments, and technical expertise. Performance will take place in Silver Spring, Maryland over a one-year...
The Department of Health and Human Services Food and Drug Administration awarded Booz Allen Hamilton Inc. a $6.8 million time-and-materials task order against the agency's Data Resource Management for Human Drug Review master blanket purchase agreement. Under this 24-month contract, Booz Allen will provide inventory control and information management support services to assist the FDA in managing data related to its review of human drugs. As the prime contractor, Booz Allen will leverage its...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) call contract to Booz Allen Hamilton Inc. for DRUG QUALITY AND SECURITY SERVICES - DQSA. The $10,600,837.15 contract, which has a completion date of July 15, 2020, was awarded on July 16, 2019 under the General Services Administration's (GSA) Professional Services Schedule (PSS). The contract is for labor hours services and does not have a set-aside designation. Booz...
Booz Allen Hamilton Inc. was awarded a $9.5 million contract by the Department of Health and Human Services' Food and Drug Administration to provide support services relating to advanced generic drug and drug quality capabilities. This contract was awarded under the prime vendor's existing FDA Safety And Innovation Act Support Services Blanket Purchase Agreement to deliver IT consulting, business analysis, data analysis and low-code software platform services in furtherance of FDA programs...
Booz Allen Hamilton Inc. was awarded a $33.4 million firm-fixed-price blanket purchase agreement call contract by the Department of Health and Human Services' Food and Drug Administration to provide services supporting existing systems. Under the terms of the multiple award schedule contract, Booz Allen will implement new features and products for the FDA in accordance with the statement of work. Performance will take place in McLean, Virginia over a three-year period through October 2024....
The Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) worth $2,082,696.91 to Booz Allen Hamilton Inc. to provide a Document Archiving Reporting and Regulatory Tracking System (DARRTS) for the Drug Quality and Security Services (DQSA) program. This BPA call under the Multiple Award Schedule (MAS) contract will support the FDA's initiatives related to drug quality and security. Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering...
This is a federal contract award by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a leading management and technology services firm, for a Pharmaceutical Quality and Compliance Platform (PQCP). The $2,495,019.10 contract is a BPA Call under the Mission Oriented Business Integrated Services (MOBIS) GSA Schedule, with a period of performance through December 2019. The contract does not have a set-aside designation. Booz Allen Hamilton Inc. is the prime contractor, and the...
Booz Allen Hamilton Inc. was awarded a $7.1 million firm-fixed-price task order against the Department of Health and Human Services Food and Drug Administration's (FDA) Data Resource Management for Human Drug Review master blanket purchase agreement. The task order is for CDER Integrated Data Management - Operations and Maintenance services in support of the FDA's Center for Drug Evaluation and Research programs. Under this task order, Booz Allen Hamilton will provide ongoing operations and...
The Department of Health and Human Services Food and Drug Administration awarded a $493,361.58 delivery order contract to Booz Allen Hamilton Inc. for a CDRH Data Processing Tool. This contract was placed under the CDER Priority Analysis master IDIQ vehicle. The contract does not have a set-aside designation. Booz Allen Hamilton is a leading provider of management, technology, and engineering services to the U.S. government, including support for federal agencies in areas such as consulting,...
The U.S. Food and Drug Administration awarded Booz Allen Hamilton Inc. a firm fixed price contract valued at approximately $543,406 to provide Salesforce development program support. As the prime contractor, Booz Allen will leverage its existing Mission Oriented Business Integrated Services (MOBIS) GSA Schedule contract vehicle to support the FDA's three-way-matching invoice clause. The two-year contract, which runs from July 2020 through September 2022, will utilize Booz Allen's expertise to...

The Department of Health and Human Services Food and Drug Administration awarded Booz Allen Hamilton Inc. a $6.97 million contract to provide Drug Quality and Security Services under the DQSA major program. To be performed in Silver Spring, Maryland over a one-year base period ending in March 2021, Booz Allen will utilize its Professional Services Schedule contract vehicle to support the FDA's efforts to ensure drug quality and security. No subcontractors or set aside designations were indicated. The contract is cost-reimbursable and will pay Booz Allen based on labor hours to assist the FDA in fulfilling its mission to protect public health by ensuring the safety and security of human and veterinary drugs.

Generated 12/25/23, 2:13 AM